Home › Funds › SABBY MANAGEMENT, LLC › INM
SABBY MANAGEMENT, LLC position in INM
InMed Pharmaceuticals Inc · Health Care
SABBY MANAGEMENT, LLC reported holding 44,970 shares of INM (InMed Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$70K, representing 0.51% of its reported portfolio and ranking #16 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed INM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's INM position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in INM in Q4 2023 at 511,934 shares (US$213.0M). Across 7 filings, SABBY MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 44,970 shares valued at US$70K — a reduction of -175,290 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2024 (shares fell 27% over the following quarter), a 80% trim in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 511.93K | $212.97M | New |
| Q1 2024 | 361.73K | $131.67K | Reduce |
| Q2 2024 | 307.24K | $81.57K | Reduce |
| Q3 2025 | 220.00K | $481.80K | New |
| Q4 2025 | 201.63K | $213.73K | Reduce |
| Q1 2026 | 220.26K | $142.05K | Add |
| Q2 2026 | 44.97K | $69.70K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INM and 13F data
INM (InMed Pharmaceuticals Inc) is a Health Care company. 19 other funds we track also report a position in INM — the largest reported positions include Vivo Capital, LLC (US$1.2M), Squadron Capital Management LLC (US$504K), Ursa Fund Management, LLC (US$195K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INM
- Vivo Capital, LLC 798.38K sh · $1.24M · Q2 2026
- Squadron Capital Management LLC 325.00K sh · $503.75K · Q2 2026
- Ursa Fund Management, LLC 125.80K sh · $194.99K · Q2 2026
- Venrock Adviser, LLC 32.69K sh · $50.66K · Q2 2026
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held INM?
SABBY MANAGEMENT, LLC has disclosed INM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.
What is SABBY MANAGEMENT, LLC's current position in INM?
As of Q2 2026, SABBY MANAGEMENT, LLC holds 44.97K shares of INM (InMed Pharmaceuticals Inc), valued at $69.70K, representing 0.51% of its reported portfolio and ranking #16.
Has SABBY MANAGEMENT, LLC been buying or selling INM?
In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC reduced its position in INM.
Which other funds hold INM?
Other major institutional holders of INM include Vivo Capital, LLC, Squadron Capital Management LLC, Ursa Fund Management, LLC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.